Cargando…

Comparison of the NG-Test Carba 5, Colloidal Gold Immunoassay (CGI) Test, and Xpert Carba-R for the Rapid Detection of Carbapenemases in Carbapenemase-Producing Organisms

Carbapenem-resistant Enterobacterales (CRE) are increasingly recognized as an urgent public health concern. The rapid and accurate identification of carbapenemases could provide insights into antimicrobial therapy and infection control. In this study, we evaluated the efficacy of three different met...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Danxia, Yan, Zelin, Cai, Chang, Li, Jiaping, Zhang, Yanyan, Wu, Yuchen, Yang, Jiaxing, Huang, Yonglu, Zhang, Rong, Wu, Yongning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952068/
https://www.ncbi.nlm.nih.gov/pubmed/36830211
http://dx.doi.org/10.3390/antibiotics12020300
_version_ 1784893538322874368
author Gu, Danxia
Yan, Zelin
Cai, Chang
Li, Jiaping
Zhang, Yanyan
Wu, Yuchen
Yang, Jiaxing
Huang, Yonglu
Zhang, Rong
Wu, Yongning
author_facet Gu, Danxia
Yan, Zelin
Cai, Chang
Li, Jiaping
Zhang, Yanyan
Wu, Yuchen
Yang, Jiaxing
Huang, Yonglu
Zhang, Rong
Wu, Yongning
author_sort Gu, Danxia
collection PubMed
description Carbapenem-resistant Enterobacterales (CRE) are increasingly recognized as an urgent public health concern. The rapid and accurate identification of carbapenemases could provide insights into antimicrobial therapy and infection control. In this study, we evaluated the efficacy of three different methods, including the NG-test Carba 5, colloidal gold immunoassay (CGI) test, and Xpert Carba-R assay, for the rapid detection of five carbapenemases (KPC, NDM, IMP, OXA-48, and VIM). A total of 207 Gram-negative strains collected from patients and hospital sewages were tested. The presence or absence of carbapenemase genes in the whole-genome sequences was used as the gold standard for evaluating the accuracy of the above-mentioned three methods. Among the 192 strains carrying only one carbapenemase gene, the accuracies of the NG-Test Carba 5, CGI test, and Xpert Carba-R were 96.88% (95% CI, 93.01–98.72%), 96.88% (95% CI, 93.01–98.72%), and 97.92% (95% CI, 94.41–99.33%), respectively. Xpert Carba-R was able to detect all 13 types of KPC variants, including KPC-2, KPC-3, KPC-25, KPC-33, KPC-35, KPC-51, KPC-52, KPC-71, KPC-76, KPC-77, KPC-78, KPC-93, and KPC-123, with a detection sensitivity of 100.00% (95% CI, 96.50–100.00%), a specificity of 100.00% (95% CI, 92.38–100.00%), and a κ index of 1.00. For IMP, Carba 5 was superior to the other two methods, with a sensitivity of 100% (95% CI, 71.66–100.00%), a specificity of 100% (95% CI, 97.38–100.00%), and a κ index of 1.00. For the remaining 15 strains carrying two or three kinds of carbapenemase genes, Carba 5 performed the best, which accurately identified all the target genes, followed by Xpert Carba-R (12/15, 80.00%) and the CGI test (10/15, 66.67%). Therefore, all three assays demonstrated reliable performances in carbapenemase detection, and Xpert Carba-R should be recommended for the detection of KPC variants, especially for patients at a high risk of infections caused by ceftazidime/avibactam-resistant strains. IMPORTANCE: CRE was listed as one of the top three pathogens that are in critical need of new antibiotics by the WHO. The rapid and accurate identification of carbapenemases is important for antimicrobial therapy and infection control. In recent years, new beta-lactam/beta-lactamase inhibitor combinations such as ceftazidime/avibactam (CZA) have been approved by the Food and Drug Administration (FDA) to cope with CRE challenges. CZA was effective against class A, class C, and some class D enzymes such as OXA-48-like. However, CZA-resistant KPC variants emerged at an alarming speed, which posed a new challenge for the accurate identification of KPC variants. In this study, we evaluated the performance of two lateral flow immunochromatographic assays, namely, NG-test Carba 5 and the CGI test, and the automated real-time quantitative PCR Xpert Carba-R in the rapid detection of carbapenemases. Notably, 13 types of KPC variants were enrolled in this study, which covered most KPC variants discovered in China. Carba-R was superior to NG-teat Carba 5 and the CGI test; it was able to detect all of the included KPC variants, including KPC-2, KPC-3, KPC-25, KPC-33, KPC-35, KPC-51, KPC-52, KPC-71, KPC-76, KPC-77, KPC-78, KPC-93, and KPC-123.
format Online
Article
Text
id pubmed-9952068
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99520682023-02-25 Comparison of the NG-Test Carba 5, Colloidal Gold Immunoassay (CGI) Test, and Xpert Carba-R for the Rapid Detection of Carbapenemases in Carbapenemase-Producing Organisms Gu, Danxia Yan, Zelin Cai, Chang Li, Jiaping Zhang, Yanyan Wu, Yuchen Yang, Jiaxing Huang, Yonglu Zhang, Rong Wu, Yongning Antibiotics (Basel) Article Carbapenem-resistant Enterobacterales (CRE) are increasingly recognized as an urgent public health concern. The rapid and accurate identification of carbapenemases could provide insights into antimicrobial therapy and infection control. In this study, we evaluated the efficacy of three different methods, including the NG-test Carba 5, colloidal gold immunoassay (CGI) test, and Xpert Carba-R assay, for the rapid detection of five carbapenemases (KPC, NDM, IMP, OXA-48, and VIM). A total of 207 Gram-negative strains collected from patients and hospital sewages were tested. The presence or absence of carbapenemase genes in the whole-genome sequences was used as the gold standard for evaluating the accuracy of the above-mentioned three methods. Among the 192 strains carrying only one carbapenemase gene, the accuracies of the NG-Test Carba 5, CGI test, and Xpert Carba-R were 96.88% (95% CI, 93.01–98.72%), 96.88% (95% CI, 93.01–98.72%), and 97.92% (95% CI, 94.41–99.33%), respectively. Xpert Carba-R was able to detect all 13 types of KPC variants, including KPC-2, KPC-3, KPC-25, KPC-33, KPC-35, KPC-51, KPC-52, KPC-71, KPC-76, KPC-77, KPC-78, KPC-93, and KPC-123, with a detection sensitivity of 100.00% (95% CI, 96.50–100.00%), a specificity of 100.00% (95% CI, 92.38–100.00%), and a κ index of 1.00. For IMP, Carba 5 was superior to the other two methods, with a sensitivity of 100% (95% CI, 71.66–100.00%), a specificity of 100% (95% CI, 97.38–100.00%), and a κ index of 1.00. For the remaining 15 strains carrying two or three kinds of carbapenemase genes, Carba 5 performed the best, which accurately identified all the target genes, followed by Xpert Carba-R (12/15, 80.00%) and the CGI test (10/15, 66.67%). Therefore, all three assays demonstrated reliable performances in carbapenemase detection, and Xpert Carba-R should be recommended for the detection of KPC variants, especially for patients at a high risk of infections caused by ceftazidime/avibactam-resistant strains. IMPORTANCE: CRE was listed as one of the top three pathogens that are in critical need of new antibiotics by the WHO. The rapid and accurate identification of carbapenemases is important for antimicrobial therapy and infection control. In recent years, new beta-lactam/beta-lactamase inhibitor combinations such as ceftazidime/avibactam (CZA) have been approved by the Food and Drug Administration (FDA) to cope with CRE challenges. CZA was effective against class A, class C, and some class D enzymes such as OXA-48-like. However, CZA-resistant KPC variants emerged at an alarming speed, which posed a new challenge for the accurate identification of KPC variants. In this study, we evaluated the performance of two lateral flow immunochromatographic assays, namely, NG-test Carba 5 and the CGI test, and the automated real-time quantitative PCR Xpert Carba-R in the rapid detection of carbapenemases. Notably, 13 types of KPC variants were enrolled in this study, which covered most KPC variants discovered in China. Carba-R was superior to NG-teat Carba 5 and the CGI test; it was able to detect all of the included KPC variants, including KPC-2, KPC-3, KPC-25, KPC-33, KPC-35, KPC-51, KPC-52, KPC-71, KPC-76, KPC-77, KPC-78, KPC-93, and KPC-123. MDPI 2023-02-02 /pmc/articles/PMC9952068/ /pubmed/36830211 http://dx.doi.org/10.3390/antibiotics12020300 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gu, Danxia
Yan, Zelin
Cai, Chang
Li, Jiaping
Zhang, Yanyan
Wu, Yuchen
Yang, Jiaxing
Huang, Yonglu
Zhang, Rong
Wu, Yongning
Comparison of the NG-Test Carba 5, Colloidal Gold Immunoassay (CGI) Test, and Xpert Carba-R for the Rapid Detection of Carbapenemases in Carbapenemase-Producing Organisms
title Comparison of the NG-Test Carba 5, Colloidal Gold Immunoassay (CGI) Test, and Xpert Carba-R for the Rapid Detection of Carbapenemases in Carbapenemase-Producing Organisms
title_full Comparison of the NG-Test Carba 5, Colloidal Gold Immunoassay (CGI) Test, and Xpert Carba-R for the Rapid Detection of Carbapenemases in Carbapenemase-Producing Organisms
title_fullStr Comparison of the NG-Test Carba 5, Colloidal Gold Immunoassay (CGI) Test, and Xpert Carba-R for the Rapid Detection of Carbapenemases in Carbapenemase-Producing Organisms
title_full_unstemmed Comparison of the NG-Test Carba 5, Colloidal Gold Immunoassay (CGI) Test, and Xpert Carba-R for the Rapid Detection of Carbapenemases in Carbapenemase-Producing Organisms
title_short Comparison of the NG-Test Carba 5, Colloidal Gold Immunoassay (CGI) Test, and Xpert Carba-R for the Rapid Detection of Carbapenemases in Carbapenemase-Producing Organisms
title_sort comparison of the ng-test carba 5, colloidal gold immunoassay (cgi) test, and xpert carba-r for the rapid detection of carbapenemases in carbapenemase-producing organisms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952068/
https://www.ncbi.nlm.nih.gov/pubmed/36830211
http://dx.doi.org/10.3390/antibiotics12020300
work_keys_str_mv AT gudanxia comparisonofthengtestcarba5colloidalgoldimmunoassaycgitestandxpertcarbarfortherapiddetectionofcarbapenemasesincarbapenemaseproducingorganisms
AT yanzelin comparisonofthengtestcarba5colloidalgoldimmunoassaycgitestandxpertcarbarfortherapiddetectionofcarbapenemasesincarbapenemaseproducingorganisms
AT caichang comparisonofthengtestcarba5colloidalgoldimmunoassaycgitestandxpertcarbarfortherapiddetectionofcarbapenemasesincarbapenemaseproducingorganisms
AT lijiaping comparisonofthengtestcarba5colloidalgoldimmunoassaycgitestandxpertcarbarfortherapiddetectionofcarbapenemasesincarbapenemaseproducingorganisms
AT zhangyanyan comparisonofthengtestcarba5colloidalgoldimmunoassaycgitestandxpertcarbarfortherapiddetectionofcarbapenemasesincarbapenemaseproducingorganisms
AT wuyuchen comparisonofthengtestcarba5colloidalgoldimmunoassaycgitestandxpertcarbarfortherapiddetectionofcarbapenemasesincarbapenemaseproducingorganisms
AT yangjiaxing comparisonofthengtestcarba5colloidalgoldimmunoassaycgitestandxpertcarbarfortherapiddetectionofcarbapenemasesincarbapenemaseproducingorganisms
AT huangyonglu comparisonofthengtestcarba5colloidalgoldimmunoassaycgitestandxpertcarbarfortherapiddetectionofcarbapenemasesincarbapenemaseproducingorganisms
AT zhangrong comparisonofthengtestcarba5colloidalgoldimmunoassaycgitestandxpertcarbarfortherapiddetectionofcarbapenemasesincarbapenemaseproducingorganisms
AT wuyongning comparisonofthengtestcarba5colloidalgoldimmunoassaycgitestandxpertcarbarfortherapiddetectionofcarbapenemasesincarbapenemaseproducingorganisms